News

OpenAI’s former No. 2 figure: AI will cure all diseases, but models alone cannot. On August 18, according to a report by Business Insider, Fidji Simo, a former OpenAI executive and co-founder of biomedical startup ChronicleBio, said that she believed that AI could eventually cure all diseases, but only

2 min read
OpenAI’s former No. 2 figure: AI will cure all diseases, but models alone will not do it. On August 18, according to Business Insider, Fidji Simo, a former OpenAI executive and co-founder of biomedical startup ChronicleBio, said that she believed that AI could eventually cure all diseases, but smarter models alone would not achieve this goal. Seamus Seamus was once the No. 2 person and head of product and business at OpenAI. However, he resigned due to chronic illness in July this year and became a part-time consultant. She responded to comments made by Anthropic CEO Dario Amodei in an X post on Monday. Amodei wrote over the weekend that AI companies need to achieve concrete breakthrough results to win over the public who are skeptical of AI. "I disagree with Dalio on most things, but he's absolutely right when he says: 'At this stage, saying AI will cure cancer is more of a cliche than an inspirational statement, and most people think it's deceptive. What really works, is to actually cure cancer,'" Simo wrote, quoting Amodei's post. Simo agrees with Amodei's point about producing practical results in medical breakthroughs. The problem is that people often directly link intelligent AI models to disease cures, without taking into account the infrastructure required between the two. She said that the bigger "bottleneck" is having "the right biological data". If there is a lack of data required to understand a specific disease, AI cannot find a treatment based on reasoning alone. “Ironically, this is why I am most bullish on AI making huge strides in cancer in the first place: decades of investment have produced incredibly rich data sets in genomics, pathology, imaging, clinical outcomes, and more,” she wrote. For more complex chronic diseases, such infrastructure doesn't yet exist, she said. via cnBeta.COM - Chinese industry information website (author: Source: Phoenix Technology)